{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:31:55Z","timestamp":1787502715585,"version":"build-2736575974"},"reference-count":126,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T00:00:00Z","timestamp":1591747200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006010","name":"Bayer Schering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015756","name":"Cilag","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015756","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.bbcan.2020.188386","type":"journal-article","created":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T20:28:58Z","timestamp":1591993738000},"page":"188386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"title":["Priming the tumor immune microenvironment with chemo(radio)therapy: A systematic review across tumor types"],"prefix":"10.1016","volume":"1874","author":[{"given":"Tom","family":"van den Ende","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9ctor G.","family":"van den Boorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine M.","family":"Hoonhout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faridi S.","family":"van Etten-Jamaludin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sybren L.","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Derks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja D.","family":"de Gruijl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten F.","family":"Bijlsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn G.H.","family":"van Oijen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanneke W.M.","family":"van Laarhoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.bbcan.2020.188386_bb0005","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMra1514296","article-title":"Molecular and biochemical aspects of the PD-1 checkpoint pathway","volume":"375","author":"Boussiotis","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.bbcan.2020.188386_bb0010","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","article-title":"Fundamental mechanisms of immune checkpoint blockade therapy","volume":"8","author":"Wei","year":"2018","journal-title":"Cancer Discov."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188386_bb0015","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41568-019-0116-x","article-title":"The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy","volume":"19","author":"Havel","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.bbcan.2020.188386_bb0020","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","article-title":"Understanding the tumor immune microenvironment (TIME) for effective therapy","volume":"24","author":"Binnewies","year":"2018","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.bbcan.2020.188386_bb0025","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1158\/1078-0432.CCR-15-1507","article-title":"The where, the when, and the how of immune monitoring for cancer immunotherapies in the era of checkpoint inhibition","volume":"22","author":"Hegde","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.bbcan.2020.188386_bb0030","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.87415","article-title":"Synergy of radiotherapy and PD-1 blockade in Kras-mutant lung cancer","volume":"1","author":"Herter-Sprie","year":"2016","journal-title":"JCI Insight"},{"issue":"15","key":"10.1016\/j.bbcan.2020.188386_bb0035","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1158\/0008-5472.CAN-17-2176","article-title":"Combined VEGF and PD-L1 blockade displays synergistic treatment effects in an autochthonous mouse model of small cell lung cancer","volume":"78","author":"Meder","year":"2018","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.bbcan.2020.188386_bb0040","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1093\/annonc\/mdy551","article-title":"Enhancing antitumor response by combining immune checkpoint inhibitors with chemotherapy in solid tumors","volume":"30","author":"Heinhuis","year":"2019","journal-title":"Ann. Oncol."},{"issue":"7","key":"10.1016\/j.bbcan.2020.188386_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"issue":"8","key":"10.1016\/j.bbcan.2020.188386_bb0050","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1093\/annonc\/mdx266","article-title":"Lymphocyte density determined by computational pathology validated as a predictor of response to neoadjuvant chemotherapy in breast cancer: secondary analysis of the ARTemis trial","volume":"28","author":"Ali","year":"2017","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.bbcan.2020.188386_bb0055","first-page":"273","article-title":"A low number of tumor-infiltrating FOXP3-positive cells during primary systemic chemotherapy correlates with favorable anti-tumor response in patients with breast cancer","volume":"22","author":"Aruga","year":"2009","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.bbcan.2020.188386_bb0060","first-page":"2311","article-title":"Prediction of treatment response to neoadjuvant chemotherapy in breast cancer by subtype using tumor-infiltrating lymphocytes","volume":"38","author":"Asano","year":"2018","journal-title":"Anticancer Res."},{"issue":"5","key":"10.1016\/j.bbcan.2020.188386_bb0065","doi-asserted-by":"crossref","first-page":"387","DOI":"10.5306\/wjco.v7.i5.387","article-title":"Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy","volume":"7","author":"Castaneda","year":"2016","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.bbcan.2020.188386_bb0070","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.oraloncology.2017.02.002","article-title":"Characterization of PD-L1 expression and immune cell infiltration in nasopharyngeal cancer","volume":"67","author":"Chan","year":"2017","journal-title":"Oral Oncol."},{"issue":"6","key":"10.1016\/j.bbcan.2020.188386_bb0075","doi-asserted-by":"crossref","first-page":"e473","DOI":"10.1016\/j.cllc.2017.04.008","article-title":"Programmed death ligand 1 expression in paired non-small cell lung cancer tumor samples","volume":"18","author":"Cho","year":"2017","journal-title":"Clin. Lung Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2020.188386_bb0080","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10549-018-4842-7","article-title":"Comparison of tumor-infiltrating lymphocytes of breast cancer in core needle biopsies and resected specimens: a retrospective analysis","volume":"171","author":"Cha","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188386_bb0085","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.5301\/jbm.5000082","article-title":"Correlation of tumor-infiltrative lymphocyte subtypes alteration with neoangiogenesis before and after neoadjuvant chemotherapy treatment in breast cancer patients","volume":"29","author":"Chan","year":"2014","journal-title":"Int. J. Biol. Markers"},{"issue":"1","key":"10.1016\/j.bbcan.2020.188386_bb0090","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/annonc\/mdx691","article-title":"A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer","volume":"29","author":"Criscitiello","year":"2018","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188386_bb0095","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ijrobp.2018.06.404","article-title":"Kinetics of intratumoral immune cell activation during chemoradiation for cervical cancer","volume":"102","author":"Dorta-Estremera","year":"2018","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"4","key":"10.1016\/j.bbcan.2020.188386_bb0100","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.ijrobp.2006.07.1362","article-title":"Effects of radiotherapy and chemotherapy on angiogenesis and leukocyte infiltration in rectal cancer","volume":"66","author":"Baeten","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"10","key":"10.1016\/j.bbcan.2020.188386_bb0105","first-page":"3025","article-title":"Development of tumor-infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy","volume":"7","author":"Demaria","year":"2001","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.bbcan.2020.188386_bb0110","first-page":"3813","article-title":"Regulatory T-cell density and cytotoxic T lymphocyte density are associated with complete response to neoadjuvant paclitaxel and carboplatin chemoradiotherapy in gastric cancer","volume":"16","author":"Huang","year":"2018","journal-title":"Exp. Ther. Med."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188386_bb0115","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/annonc\/mdt556","article-title":"Prognostic value of tumor-infiltrating lymphocytes on residual disease after primary chemotherapy for triple-negative breast cancer: a retrospective multicenter study","volume":"25","author":"Dieci","year":"2014","journal-title":"Ann. Oncol."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188386_bb0120","doi-asserted-by":"crossref","first-page":"204","DOI":"10.14735\/amko2016204","article-title":"Changes in the CD8<sup>+<\/sup> density of tumor infiltrating lymphocytes after neoadjuvant radiochemotherapy in patients with rectal adenocarcinoma. [Czech]","volume":"29","author":"Buka","year":"2016","journal-title":"Klin. Onkol."},{"issue":"18","key":"10.1016\/j.bbcan.2020.188386_bb0125","doi-asserted-by":"crossref","first-page":"30175","DOI":"10.18632\/oncotarget.15621","article-title":"Prognostic significance of tumor-infiltrating immune cells and PD-L1 expression in esophageal squamous cell carcinoma","volume":"8","author":"Jiang","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.bbcan.2020.188386_bb0130","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00262-018-2275-0","article-title":"Upregulation of tumor PD-L1 by neoadjuvant chemoradiotherapy (neoCRT) confers improved survival in patients with lymph node metastasis of locally advanced rectal cancers","volume":"68","author":"Chiang","year":"2019","journal-title":"Cancer Immunology, Immunotherapy"},{"issue":"10","key":"10.1016\/j.bbcan.2020.188386_bb0135","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1093\/annonc\/mdw262","article-title":"Integrated evaluation of PAM50 subtypes and immune modulation of pCR in HER2-positive breast cancer patients treated with chemotherapy and HER2-targeted agents in the CherLOB trial","volume":"27","author":"Dieci","year":"2016","journal-title":"Ann. Oncol."},{"issue":"12","key":"10.1016\/j.bbcan.2020.188386_bb0140","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1158\/1078-0432.CCR-15-2657","article-title":"Neoadjuvant chemotherapy modulates the immune microenvironment in metastases of tubo-ovarian high-grade serous carcinoma","volume":"22","author":"Bohm","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2020.188386_bb0145","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13000-018-0770-4","article-title":"Tumor-infiltrating CD8+ and FOXP3+ lymphocytes before and after neoadjuvant chemotherapy in cervical cancer","volume":"13","author":"Liang","year":"2018","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.bbcan.2020.188386_bb0150","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejca.2016.06.015","article-title":"PD-L1 is upregulated by radiochemotherapy in rectal adenocarcinoma patients and associated with a favourable prognosis","volume":"65","author":"Hecht","year":"2016","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/j.bbcan.2020.188386_bb0155","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.clbc.2018.02.010","article-title":"Early stage HER2-positive breast cancers not achieving a pCR from neoadjuvant trastuzumab- or pertuzumab-based regimens have an immunosuppressive phenotype","volume":"18","author":"Force","year":"2018","journal-title":"Clin. Breast Cancer"},{"issue":"6","key":"10.1016\/j.bbcan.2020.188386_bb0160","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1097\/SLA.0000000000002410","article-title":"The dynamic and transient immune microenvironment in locally advanced esophageal adenocarcinoma post chemoradiation","volume":"268","author":"Kelly","year":"2018","journal-title":"Ann. Surg."},{"issue":"2","key":"10.1016\/j.bbcan.2020.188386_bb0165","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1393133","article-title":"Neoadjuvant radiochemotherapy decreases the total amount of tumor infiltrating lymphocytes, but increases the number of CD8+\/Granzyme B+ (GrzB) cytotoxic T-cells in rectal cancer","volume":"7","author":"Jarosch","year":"2018","journal-title":"Oncoimmunology"},{"issue":"6","key":"10.1016\/j.bbcan.2020.188386_bb0170","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1186\/s13058-014-0488-5","article-title":"Tumor-infiltrating immune cell profiles and their change after neoadjuvant chemotherapy predict response and prognosis of breast cancer","volume":"16","author":"Garcia-Martinez","year":"2014","journal-title":"Breast Cancer Res."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188386_bb0175","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.ygyno.2018.08.023","article-title":"Expression of programmed cell death ligand 1 and immune checkpoint markers in residual tumors after neoadjuvant chemotherapy for advanced high-grade serous ovarian cancer","volume":"151","author":"Kim","year":"2018","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.bbcan.2020.188386_bb0180","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s10353-016-0447-8","article-title":"Programmed death-ligand 1 expression in rectal cancer","volume":"48","author":"Jomrich","year":"2016","journal-title":"Eur. Surg."},{"issue":"4","key":"10.1016\/j.bbcan.2020.188386_bb0185","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1158\/1078-0432.CCR-16-1433","article-title":"Neoadjuvant chemotherapy of ovarian cancer results in three patterns of tumor-infiltrating lymphocyte response with distinct implications for immunotherapy","volume":"23","author":"Lo","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.bbcan.2020.188386_bb0190","first-page":"6505","article-title":"Effect of neoadjuvant chemoradiation on tumor-infiltrating\/associated lymphocytes in locally advanced rectal cancers","volume":"34","author":"Lim","year":"2014","journal-title":"Anticancer Res."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188386_bb0195","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1093\/annonc\/mdw625","article-title":"Neoadjuvant chemotherapy (NACT) increases immune infiltration and programmed death-ligand 1 (PD-L1) expression in epithelial ovarian cancer (EOC)","volume":"28","author":"Mesnage","year":"2017","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/j.bbcan.2020.188386_bb0200","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.ijrobp.2017.07.004","article-title":"Chemoradiation-induced alteration of programmed death-ligand 1 and CD8(+) tumor-infiltrating lymphocytes identified patients with poor prognosis in rectal cancer: a matched comparison analysis","volume":"99","author":"Lim","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"6","key":"10.1016\/j.bbcan.2020.188386_bb0205","doi-asserted-by":"crossref","DOI":"10.1136\/esmoopen-2017-000305","article-title":"Predictive value of improvement in the immune tumour microenvironment in patients with breast cancer treated with neoadjuvant chemotherapy","volume":"3","author":"Goto","year":"2018","journal-title":"ESMO Open"},{"issue":"5","key":"10.1016\/j.bbcan.2020.188386_bb0210","first-page":"2929","article-title":"Eribulin promotes antitumor immune responses in patients with locally advanced or metastatic breast cancer","volume":"38","author":"Goto","year":"2018","journal-title":"Anticancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2020.188386_bb0215","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/cam4.1943","article-title":"The prognostic impact of programmed cell death 1 and its ligand and the correlation with epithelial-mesenchymal transition in thymic carcinoma","volume":"8","author":"Funaki","year":"2019","journal-title":"Cancer Med."},{"issue":"9","key":"10.1016\/j.bbcan.2020.188386_bb0220","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1093\/annonc\/mdx309","article-title":"Stromal lymphocyte infiltration after neoadjuvant chemotherapy is associated with aggressive residual disease and lower disease-free survival in HER2-positive breast cancer.","volume":"28","author":"Hamy","year":"2017","journal-title":"Annals of Oncology\u202f: Official Journal of the European Society for Medical Oncology."},{"issue":"4","key":"10.1016\/j.bbcan.2020.188386_bb0225","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/cas.13542","article-title":"Significance of tumor-infiltrating lymphocytes before and after neoadjuvant therapy for rectal cancer","volume":"109","author":"Matsutani","year":"2018","journal-title":"Cancer Sci."},{"issue":"10","key":"10.1016\/j.bbcan.2020.188386_bb0230","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1080\/07357900802098165","article-title":"Tumor-infiltrating lymphocytes predict response to neoadjuvant chemotherapy in patients with breast carcinoma","volume":"26","author":"Hornychova","year":"2008","journal-title":"Cancer Investig."},{"key":"10.1016\/j.bbcan.2020.188386_bb0235","article-title":"A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients","author":"Hwang","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbcan.2020.188386_bb0240","doi-asserted-by":"crossref","first-page":"4757405","DOI":"10.1155\/2016\/4757405","article-title":"Crucial contributions by T lymphocytes (effector, regulatory, and checkpoint inhibitor) and cytokines (TH1, TH2, and TH17) to a pathological complete response induced by neoadjuvant chemotherapy in women with breast cancer","volume":"2016","author":"Kaewkangsadan","year":"2016","journal-title":"J Immunol Res"},{"key":"10.1016\/j.bbcan.2020.188386_bb0245","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.lungcan.2016.05.007","article-title":"Expression of programmed death 1 (PD-1) and its ligand (PD-L1) in thymic epithelial tumors: impact on treatment efficacy and alteration in expression after chemotherapy","volume":"99","author":"Katsuya","year":"2016","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bbcan.2020.188386_bb0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2015.09.019","article-title":"Changes in tumour expression of programmed death-ligand 1 after neoadjuvant concurrent chemoradiotherapy in patients with squamous oesophageal cancer","volume":"52","author":"Lim","year":"2016","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2020.188386_bb0255","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1385689","article-title":"Analysis of the immune infiltrate in undifferentiated pleomorphic sarcoma of the extremity and trunk in response to radiotherapy: rationale for combination neoadjuvant immune checkpoint inhibition and radiotherapy","volume":"7","author":"Keung","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bbcan.2020.188386_bb0260","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1049023","article-title":"The differential contribution of the innate immune system to a good pathological response in the breast and axillary lymph nodes induced by neoadjuvant chemotherapy in women with large and locally advanced breast cancers","volume":"2017","author":"Kaewkangsadan","year":"2017","journal-title":"J Immunol Res"},{"key":"10.1016\/j.bbcan.2020.188386_bb0265","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.breast.2018.08.103","article-title":"Chemosensitivity, tumor infiltrating lymphocytes (TILs), and survival of postpartum PABC patients treated by neoadjuvant chemotherapy","volume":"42","author":"Labrosse","year":"2018","journal-title":"Breast"},{"issue":"1","key":"10.1016\/j.bbcan.2020.188386_bb0270","article-title":"TPF induction chemotherapy increases PD-L1 expression in tumour cells and immune cells in head and neck squamous cell carcinoma","volume":"3","author":"Leduc","year":"2018","journal-title":"ESMO Open"},{"issue":"8","key":"10.1016\/j.bbcan.2020.188386_bb0275","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1158\/1078-0432.CCR-07-4491","article-title":"Pathologic complete response to neoadjuvant chemotherapy of breast carcinoma is associated with the disappearance of tumor-infiltrating foxp3+ regulatory T cells","volume":"14","author":"Ladoire","year":"2008","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188386_bb0280","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1396402","article-title":"Tumor lymphocyte immune response to preoperative radiotherapy in locally advanced rectal cancer: the LYMPHOREC study","volume":"7","author":"Mirjolet","year":"2018","journal-title":"Oncoimmunology"},{"issue":"6","key":"10.1016\/j.bbcan.2020.188386_bb0285","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1007\/s10147-018-1305-4","article-title":"Changes in programmed death ligand 1 expression in non-small cell lung cancer patients who received anticancer treatments","volume":"23","author":"Omori","year":"2018","journal-title":"Int. J. Clin. Oncol."},{"issue":"38","key":"10.1016\/j.bbcan.2020.188386_bb0290","doi-asserted-by":"crossref","first-page":"63901","DOI":"10.18632\/oncotarget.19194","article-title":"EGFR or HER2 inhibition modulates the tumor microenvironment by suppression of PD-L1 and cytokines release","volume":"8","author":"Suh","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.bbcan.2020.188386_bb0295","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/bjc.2011.261","article-title":"T-bet expression in intratumoral lymphoid structures after neoadjuvant trastuzumab plus docetaxel for HER2-overexpressing breast carcinoma predicts survival","volume":"105","author":"Ladoire","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.bbcan.2020.188386_bb0300","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/path.2866","article-title":"In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival","volume":"224","author":"Ladoire","year":"2011","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbcan.2020.188386_bb0305","article-title":"Prognostic role and clinical association of tumor-infiltrating lymphocyte, programmed death Ligand-1 expression with neutrophil-lymphocyte ratio in locally advanced triple-negative breast cancer","author":"Lee","year":"2018","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.bbcan.2020.188386_bb0310","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40425-016-0163-8","article-title":"5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers","volume":"4","author":"Van Der Kraak","year":"2016","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbcan.2020.188386_bb0315","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejca.2017.12.005","article-title":"Pattern of programmed cell death-ligand 1 expression and CD8-positive T-cell infiltration before and after chemoradiotherapy in rectal cancer","volume":"91","author":"Ogura","year":"2018","journal-title":"Eur. J. Cancer"},{"issue":"37","key":"10.1016\/j.bbcan.2020.188386_bb0320","doi-asserted-by":"crossref","first-page":"60383","DOI":"10.18632\/oncotarget.11039","article-title":"Spatial distribution of FoxP3+ and CD8+ tumour infiltrating T cells reflects their functional activity","volume":"7","author":"Posselt","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bbcan.2020.188386_bb0325","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s40425-018-0403-1","article-title":"Targeting VEGFR2 with Ramucirumab strongly impacts effector\/ activated regulatory T cells and CD8(+) T cells in the tumor microenvironment","volume":"6","author":"Tada","year":"2018","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2020.188386_bb0330","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10120-018-0842-x","article-title":"Discordancy and changes in the pattern of programmed death ligand 1 expression before and after platinum-based chemotherapy in metastatic gastric cancer","volume":"22","author":"Yang","year":"2019","journal-title":"Gastric Cancer"},{"issue":"12","key":"10.1016\/j.bbcan.2020.188386_bb0335","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1255394","article-title":"Immune contexture and histological response after neoadjuvant chemotherapy predict clinical outcome of lung cancer patients","volume":"5","author":"Remark","year":"2016","journal-title":"Oncoimmunology"},{"issue":"6","key":"10.1016\/j.bbcan.2020.188386_bb0340","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1435227","article-title":"Potential immune priming of the tumor microenvironment with FOLFOX chemotherapy in locally advanced rectal cancer","volume":"7","author":"Roxburgh","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bbcan.2020.188386_bb0345","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.lungcan.2018.11.025","article-title":"Impact of cytotoxic chemotherapy on PD-L1 expression in patients with non-small cell lung cancer negative for EGFR mutation and ALK fusion","volume":"127","author":"Sakai","year":"2019","journal-title":"Lung Cancer"},{"issue":"Suppl. 1","key":"10.1016\/j.bbcan.2020.188386_bb0350","article-title":"Can macrophages within the microenvironment of locally invasive rectal cancers predict response to radiotherapy?","volume":"385","author":"Shaikh","year":"2015","journal-title":"Lancet"},{"issue":"Suppl. 3","key":"10.1016\/j.bbcan.2020.188386_bb0355","doi-asserted-by":"crossref","first-page":"S414","DOI":"10.1245\/s10434-014-3584-y","article-title":"CD8+ and FOXP3+ tumor-infiltrating T cells before and after chemoradiotherapy for rectal cancer","volume":"21","author":"Shinto","year":"2014","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.bbcan.2020.188386_bb0360","doi-asserted-by":"crossref","first-page":"20090","DOI":"10.1038\/srep20090","article-title":"Expression of programmed death ligand-1 on tumor cells varies pre and post chemotherapy in non-small cell lung cancer","volume":"6","author":"Sheng","year":"2016","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.bbcan.2020.188386_bb0365","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s00262-010-0817-1","article-title":"Foxp3(+) cell infiltration and granzyme B(+)\/Foxp3(+) cell ratio are associated with outcome in neoadjuvant chemotherapy-treated ovarian carcinoma","volume":"59","author":"Polcher","year":"2010","journal-title":"Cancer Immunol. Immunother."},{"issue":"2","key":"10.1016\/j.bbcan.2020.188386_bb0370","first-page":"277","article-title":"Assessment of PD-1 positive cells on initial and secondary resected tumor specimens of newly diagnosed glioblastoma and its implications on patient outcome","volume":"133","author":"Miyazaki","year":"2017","journal-title":"J. Dermatol."},{"issue":"6","key":"10.1016\/j.bbcan.2020.188386_bb0375","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.trsl.2015.06.019","article-title":"Tumor-infiltrating lymphocytes, forkhead box P3, programmed death ligand-1, and cytotoxic T lymphocyte-associated antigen-4 expressions before and after neoadjuvant chemoradiation in rectal cancer","volume":"166","author":"Teng","year":"2015","journal-title":"Transl. Res."},{"issue":"1","key":"10.1016\/j.bbcan.2020.188386_bb0380","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s40425-018-0438-3","article-title":"RAS status and neoadjuvant chemotherapy impact CD8+ cells and tumor HLA class I expression in liver metastatic colorectal cancer","volume":"6","author":"Ledys","year":"2018","journal-title":"J. Immunother. Cancer"},{"issue":"5","key":"10.1016\/j.bbcan.2020.188386_bb0385","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1093\/annonc\/mdy086","article-title":"Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over time","volume":"29","author":"Pasello","year":"2018","journal-title":"Ann. Oncol."},{"issue":"2","key":"10.1016\/j.bbcan.2020.188386_bb0390","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s10549-012-2132-3","article-title":"Peritumoral FOXP3(+) regulatory T cell is sensitive to chemotherapy while intratumoral FOXP3(+) regulatory T cell is prognostic predictor of breast cancer patients","volume":"135","author":"Liu","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbcan.2020.188386_bb0395","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.lungcan.2016.07.013","article-title":"Altered expression of programmed death-ligand 1 after neo-adjuvant chemotherapy in patients with lung squamous cell carcinoma","volume":"99","author":"Song","year":"2016","journal-title":"Lung Cancer"},{"issue":"6","key":"10.1016\/j.bbcan.2020.188386_bb0400","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1158\/1078-0432.CCR-15-1125","article-title":"RAS\/MAPK activation is associated with reduced tumor-infiltrating lymphocytes in triple-negative breast cancer: therapeutic cooperation between MEK and PD-1\/PD-L1 immune checkpoint inhibitors","volume":"22","author":"Loi","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2020.188386_bb0405","article-title":"Prognostic implications of residual disease tumor-infiltrating lymphocytes and residual cancer burden in triple negative breast cancer patients after neo-adjuvant chemotherapy","author":"Luen","year":"2018","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.bbcan.2020.188386_bb0410","first-page":"2064","article-title":"Tumor infiltrating lymphocytes (TILs) before and after neoadjuvant chemoradiotherapy and its clinical utility for rectal cancer","volume":"5","author":"Teng","year":"2015","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.bbcan.2020.188386_bb0415","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13058-015-0632-x","article-title":"Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study","volume":"17","author":"Miyashita","year":"2015","journal-title":"Breast Cancer Res."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188386_bb0420","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/S11670-008-0222-X","article-title":"Effect of tumor infiltrating lymphocyte on local control of rectal cancer after preoperative radiotherapy","volume":"20","author":"Xu","year":"2008","journal-title":"Chin. J. Cancer Res."},{"issue":"5","key":"10.1016\/j.bbcan.2020.188386_bb0425","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1667\/RR3155.1","article-title":"In situ observation of the effects of local irradiation on cytotoxic and regulatory T lymphocytes in cervical cancer tissue","volume":"179","author":"Qinfeng","year":"2013","journal-title":"Radiat. Res."},{"issue":"2","key":"10.1016\/j.bbcan.2020.188386_bb0430","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3892\/ijo.2016.3540","article-title":"Clonal expansion of antitumor T cells in breast cancer correlates with response to neoadjuvant chemotherapy","volume":"49","author":"Park","year":"2016","journal-title":"Int. J. Oncol."},{"issue":"11","key":"10.1016\/j.bbcan.2020.188386_bb0435","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/cas.13072","article-title":"Upregulation of programmed cell death ligand 1 promotes resistance response in non-small-cell lung cancer patients treated with neo-adjuvant chemotherapy","volume":"107","author":"Zhang","year":"2016","journal-title":"Cancer Sci."},{"issue":"1","key":"10.1016\/j.bbcan.2020.188386_bb0440","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s13058-017-0884-8","article-title":"Effect of neoadjuvant chemotherapy on tumor-infiltrating lymphocytes and PD-L1 expression in breast cancer and its clinical significance","volume":"19","author":"Pelekanou","year":"2017","journal-title":"Breast Cancer Res."},{"issue":"6","key":"10.1016\/j.bbcan.2020.188386_bb0445","first-page":"1324","article-title":"Tumor-infiltrating lymphocytes and PD-L1 expression in pre- and posttreatment breast cancers in the SWOG S0800 phase II neoadjuvant chemotherapy trial","volume":"17","author":"Pelekanou","year":"2018","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.bbcan.2020.188386_bb0450","first-page":"1062","article-title":"Correlation between tumor microenvironment-associated factors and the efficacy and prognosis of neoadjuvant therapy for rectal cancer","volume":"17","author":"Zhang","year":"2019","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.bbcan.2020.188386_bb0455","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4048\/jbc.2018.21.2.124","article-title":"Lymphocyte-activation Gene-3 expression and prognostic value in neoadjuvant-treated triple-negative breast cancer","volume":"21","author":"Wang","year":"2018","journal-title":"J. Breast Cancer"},{"issue":"1","key":"10.1016\/j.bbcan.2020.188386_bb0460","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s10549-017-4575-z","article-title":"Abundant tumor infiltrating lymphocytes after primary systemic chemotherapy predicts poor prognosis in estrogen receptor-positive\/HER2-negative breast cancers","volume":"168","author":"Watanabe","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.bbcan.2020.188386_bb0465","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.humpath.2018.05.024","article-title":"Tumor-infiltrating lymphocyte volume is a better predictor of neoadjuvant therapy response and overall survival in triple-negative invasive breast cancer","volume":"80","author":"Zhang","year":"2018","journal-title":"Hum. Pathol."},{"issue":"67","key":"10.1016\/j.bbcan.2020.188386_bb0470","first-page":"111836","article-title":"Tumoral immune-infiltrate (IF), PD-L1 expression and role of CD8\/TIA-1 lymphocytes in localized osteosarcoma patients treated within protocol ISG-OS1","volume":"8","author":"Palmerini","year":"2017","journal-title":"Sci. Transl. Med."},{"issue":"17","key":"10.1016\/j.bbcan.2020.188386_bb0475","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1158\/1078-0432.CCR-13-0352","article-title":"Radiotherapy of human sarcoma promotes an intratumoral immune effector signature","volume":"19","author":"Sharma","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.bbcan.2020.188386_bb0480","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.oraloncology.2012.01.024","article-title":"Radiochemotherapy induces a favourable tumour infiltrating inflammatory cell profile in head and neck cancer","volume":"48","author":"Tabachnyk","year":"2012","journal-title":"Oral Oncol."},{"issue":"4","key":"10.1016\/j.bbcan.2020.188386_bb0485","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1001\/jamadermatol.2016.5062","article-title":"Association between programmed death ligand 1 expression in patients with basal cell carcinomas and the number of treatment modalities","volume":"153","author":"Chang","year":"2017","journal-title":"JAMA Dermatol."},{"issue":"4","key":"10.1016\/j.bbcan.2020.188386_bb0490","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/bjc.2013.362","article-title":"Tumour-infiltrating CD68+ and CD57+ cells predict patient outcome in stage II-III colorectal cancer","volume":"109","author":"Chaput","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbcan.2020.188386_bb0495","doi-asserted-by":"crossref","DOI":"10.1007\/s10120-018-00918-4","article-title":"Predictive value of MLH1 and PD-L1 expression for prognosis and response to preoperative chemotherapy in gastric cancer","author":"Hashimoto","year":"2019","journal-title":"Gastric Cancer"},{"issue":"2","key":"10.1016\/j.bbcan.2020.188386_bb0500","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1054598","article-title":"Tumor infiltration by Tbet+ effector T cells and CD20+ B cells is associated with survival in gastric cancer patients","volume":"5","author":"Hennequin","year":"2016","journal-title":"Oncoimmunology"},{"issue":"2","key":"10.1016\/j.bbcan.2020.188386_bb0505","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1245\/s10434-013-3390-y","article-title":"Immunological impact of neoadjuvant chemoradiotherapy in patients with borderline resectable pancreatic ductal adenocarcinoma","volume":"21","author":"Homma","year":"2014","journal-title":"Ann. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188386_bb0510","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/cas.13162","article-title":"Cetuximab strongly enhances immune cell infiltration into liver metastatic sites in colorectal cancer","volume":"108","author":"Inoue","year":"2017","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2020.188386_bb0515","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.2147\/OTT.S101884","article-title":"Decreased FOXP3+ and GARP+ Tregs to neoadjuvant chemotherapy associated with favorable prognosis in advanced gastric cancer","volume":"9","author":"Li","year":"2016","journal-title":"Oncol. Targets Ther."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188386_bb0520","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/jso.24681","article-title":"Neoadjuvant chemoradiotherapy of pancreatic cancer induces a favorable immunogenic tumor microenvironment associated with increased major histocompatibility complex class I-related chain A\/B expression","volume":"116","author":"Murakami","year":"2017","journal-title":"J. Surg. Oncol."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188386_bb0525","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1593\/neo.05733","article-title":"The B7-H1 (PD-L1) T lymphocyte-inhibitory molecule is expressed in breast cancer patients with infiltrating ductal carcinoma: correlation with important high-risk prognostic factors","volume":"8","author":"Ghebeh","year":"2006","journal-title":"Neoplasia"},{"issue":"3","key":"10.1016\/j.bbcan.2020.188386_bb0530","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.ygyno.2016.12.021","article-title":"Tumor-associated macrophage expression of PD-L1 in implants of high grade serous ovarian carcinoma: a comparison of matched primary and metastatic tumors","volume":"144","author":"Gottlieb","year":"2017","journal-title":"Gynecol. Oncol."},{"issue":"11","key":"10.1016\/j.bbcan.2020.188386_bb0535","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/bjs.4338","article-title":"Effect of neoadjuvant chemoradiotherapy on angiogenesis in oesophageal cancer","volume":"90","author":"McDonnell","year":"2003","journal-title":"Br. J. Surg."},{"issue":"1","key":"10.1016\/j.bbcan.2020.188386_bb0540","doi-asserted-by":"crossref","first-page":"958","DOI":"10.3892\/ol.2017.6215","article-title":"MLH1 expression predicts the response to preoperative therapy and is associated with PD-L1 expression in esophageal cancer","volume":"14","author":"Momose","year":"2017","journal-title":"Oncol. Lett."},{"issue":"6","key":"10.1016\/j.bbcan.2020.188386_bb0545","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00262-016-1826-5","article-title":"Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma","volume":"65","author":"Noble","year":"2016","journal-title":"Cancer Immunol. Immunother."},{"issue":"12","key":"10.1016\/j.bbcan.2020.188386_bb0550","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1007\/s00262-017-2050-7","article-title":"Mucosa-associated invariant T cells infiltrate hepatic metastases in patients with colorectal carcinoma but are rendered dysfunctional within and adjacent to tumor microenvironment","volume":"66","author":"Shaler","year":"2017","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bbcan.2020.188386_bb0555","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.humpath.2017.06.009","article-title":"Prognostic significance of IgG4+ plasma cell infiltrates following neoadjuvant chemoradiation therapy for esophageal adenocarcinoma","volume":"66","author":"Yakirevich","year":"2017","journal-title":"Hum. Pathol."},{"issue":"12","key":"10.1016\/j.bbcan.2020.188386_bb0560","doi-asserted-by":"crossref","first-page":"11837","DOI":"10.1007\/s13277-014-2410-2","article-title":"Impact of neoadjuvant chemotherapy on lymphocytes and co-inhibitory B7-H4 molecule in gastric cancer: low B7-H4 expression associates with favorable prognosis","volume":"35","author":"Maskey","year":"2014","journal-title":"Tumour Biol."},{"issue":"1","key":"10.1016\/j.bbcan.2020.188386_bb0565","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40425-018-0368-0","article-title":"Effect of neoadjuvant chemotherapy on the immune microenvironment in non-small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches","volume":"6","author":"Parra","year":"2018","journal-title":"J. Immunother. Cancer"},{"issue":"8","key":"10.1016\/j.bbcan.2020.188386_bb0570","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1073\/pnas.1104303108","article-title":"Leukocyte composition of human breast cancer","volume":"109","author":"Ruffell","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"12","key":"10.1016\/j.bbcan.2020.188386_bb0575","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.ejso.2009.07.002","article-title":"Influence of neoadjuvant radio-chemotherapy on tumor-infiltrating lymphocytes in squamous esophageal cancer","volume":"35","author":"Zingg","year":"2009","journal-title":"Eur. J. Surg. Oncol."},{"issue":"7","key":"10.1016\/j.bbcan.2020.188386_bb0580","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.ejso.2010.05.012","article-title":"Tumour-infiltrating lymphocytes and survival in patients with adenocarcinoma of the oesophagus","volume":"36","author":"Zingg","year":"2010","journal-title":"Eur. J. Surg. Oncol."},{"issue":"5","key":"10.1016\/j.bbcan.2020.188386_bb0585","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/cas.12119","article-title":"Novel aspects of preoperative chemoradiation therapy improving anti-tumor immunity in pancreatic cancer","volume":"104","author":"Tsuchikawa","year":"2013","journal-title":"Cancer Sci."},{"issue":"58","key":"10.1016\/j.bbcan.2020.188386_bb0590","doi-asserted-by":"crossref","first-page":"97920","DOI":"10.18632\/oncotarget.18542","article-title":"Changes in programmed death-ligand 1 expression during cisplatin treatment in patients with head and neck squamous cell carcinoma","volume":"8","author":"Ock","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.bbcan.2020.188386_bb0595","doi-asserted-by":"crossref","first-page":"11373","DOI":"10.1038\/s41598-017-11949-9","article-title":"Alteration of PD-L1 expression and its prognostic impact after concurrent chemoradiation therapy in non-small cell lung cancer patients","volume":"7","author":"Fujimoto","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2020.188386_bb0600","first-page":"1049023","article-title":"The differential contribution of the innate immune system to a good pathological response in the breast and axillary lymph nodes induced by neoadjuvant chemotherapy in women with large and locally advanced breast cancers","volume":"2017","author":"Kaewkangsadan","year":"2017","journal-title":"Pathol. Oncol. Res."},{"issue":"10","key":"10.1016\/j.bbcan.2020.188386_bb0605","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1158\/1078-0432.CCR-18-3781","article-title":"Targeting the tumor microenvironment in radiation oncology: proceedings from the 2018 ASTRO-AACR research workshop","volume":"25","author":"McGee","year":"2019","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.bbcan.2020.188386_bb0610","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.immuni.2014.10.019","article-title":"STING-dependent cytosolic DNA sensing promotes radiation-induced type I interferon-dependent antitumor immunity in immunogenic tumors","volume":"41","author":"Deng","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.bbcan.2020.188386_bb0615","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/978-3-319-67577-0_2","article-title":"Cancer immunotherapy targets based on understanding the T cell-inflamed versus non-T cell-inflamed tumor microenvironment","volume":"1036","author":"Gajewski","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"issue":"3","key":"10.1016\/j.bbcan.2020.188386_bb0620","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/s41416-019-0515-5","article-title":"Can PD-L1 expression evaluated by biopsy sample accurately reflect its expression in the whole tumour in gastric cancer?","volume":"121","author":"Yamashita","year":"2019","journal-title":"Br. J. Cancer"},{"issue":"14","key":"10.1016\/j.bbcan.2020.188386_bb0625","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1158\/0008-5472.CAN-14-3477","article-title":"Noninvasive imaging of tumor PD-L1 expression using radiolabeled anti-PD-L1 antibodies","volume":"75","author":"Heskamp","year":"2015","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.bbcan.2020.188386_bb0630","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1158\/2326-6066.CIR-18-0280","article-title":"PD-L1 microSPECT\/CT imaging for longitudinal monitoring of PD-L1 expression in syngeneic and humanized mouse models for cancer","volume":"7","author":"Heskamp","year":"2019","journal-title":"Cancer Immunol. Res."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X20301050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X20301050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:30:35Z","timestamp":1759638635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X20301050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":126,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0304419X20301050"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2020.188386","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Priming the tumor immune microenvironment with chemo(radio)therapy: A systematic review across tumor types","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2020.188386","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"188386"}}